Halozyme Therapeutics, Inc. (0J2O.L)
USD 48.78
(0.12%)
USD 48.78
(0.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 829.25 Million | 660.11 Million | 443.31 Million | 267.59 Million | 195.99 Million | 151.86 Million |
| Cost of Revenue | 192.36 Million | 139.3 Million | 81.41 Million | 43.36 Million | 45.54 Million | 10.13 Million |
| Gross Profit | 636.89 Million | 520.81 Million | 361.89 Million | 224.22 Million | 150.44 Million | 141.72 Million |
| Operating Expenses | 299.31 Million | 253.28 Million | 85.99 Million | 79.97 Million | 218.05 Million | 211.05 Million |
| Selling, General and Administrative Expenses | 149.18 Million | 143.52 Million | 50.32 Million | 45.73 Million | 77.25 Million | 60.8 Million |
| Research and Development Expenses | 76.36 Million | 66.6 Million | 35.67 Million | 34.23 Million | 140.8 Million | 150.25 Million |
| Other Expenses | 73.77 Million | 43.14 Million | - | - | - | - |
| Cost and Expenses | 491.67 Million | 392.58 Million | 167.4 Million | 123.33 Million | 263.6 Million | 221.19 Million |
| Operating Income | 337.57 Million | 267.53 Million | 275.9 Million | 144.25 Million | -67.61 Million | -69.33 Million |
| Interest Expense | 18.76 Million | 16.94 Million | 7.52 Million | 20.37 Million | 11.62 Million | 18.04 Million |
| Income Tax Expense | 66.73 Million | 46.78 Million | -154.19 Million | 217 Thousand | -11 Thousand | 537 Thousand |
| Earnings before Tax | 348.32 Million | 248.91 Million | 248.51 Million | 129.3 Million | -72.25 Million | -79.79 Million |
| Net Income | 281.59 Million | 202.12 Million | 402.71 Million | 129.08 Million | -72.24 Million | -80.33 Million |
| Earnings Per Share Basic | 2.13 | 1.48 | 2.86 | 0.95 | -0.50 | -0.56 |
| Earnings Per Share Diluted | 2.10 | 1.44 | 2.74 | 0.91 | -0.50 | -0.56 |
| Weighted Average Shares Outstanding | 131.92 Million | 136.84 Million | 140.64 Million | 136.2 Million | 144.32 Million | 143.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 134.19 Million | 140.6 Million | 146.79 Million | 141.46 Million | 144.32 Million | 143.59 Million |
| Gross Margin | 0.77 | 0.79 | 0.82 | 0.84 | 0.77 | 0.93 |
| EBIT Margin | 0.55 | 0.47 | 0.62 | 0.54 | -0.34 | -0.46 |
| Profit Margin | 0.34 | 0.31 | 0.91 | 0.48 | -0.37 | -0.53 |
| EBITDA | 451.94 Million | 315.5 Million | 259.04 Million | 152.96 Million | -56.55 Million | -69.33 Million |
| Earnings Before Tax Margin | 0.41 | 0.41 | 0.62 | 0.54 | -0.34 | -0.46 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 290.08 Million | 231.35 Million | 195.87 Million | 230.03 Million | 829.25 Million | 216.03 Million |
| Cost of Revenue | 49.42 Million | 57.36 Million | 46.09 Million | 52.29 Million | 192.36 Million | 54.82 Million |
| Gross Profit | 240.65 Million | 173.98 Million | 149.78 Million | 177.74 Million | 636.89 Million | 161.21 Million |
| Operating Expenses | 77.46 Million | 56.74 Million | 54.24 Million | 76.7 Million | 299.31 Million | 72.93 Million |
| Selling, General and Administrative Expenses | 41.24 Million | 35.71 Million | 35.13 Million | 37.6 Million | - | 35.26 Million |
| Research and Development Expenses | 18.45 Million | 21.03 Million | 19.11 Million | 21.33 Million | - | 17.32 Million |
| Other Expenses | 17.76 Million | 17.76 Million | 17.76 Million | 17.76 Million | 73.77 Million | 20.34 Million |
| Cost and Expenses | 126.88 Million | 114.11 Million | 100.33 Million | 129 Million | 491.67 Million | 127.75 Million |
| Operating Income | 163.19 Million | 117.23 Million | 95.54 Million | 101.03 Million | 337.57 Million | 88.27 Million |
| Interest Expense | -4.52 Million | 4.52 Million | 4.5 Million | 5.22 Million | 18.76 Million | 4.5 Million |
| Income Tax Expense | 28.13 Million | 24.49 Million | 19.2 Million | 15.78 Million | 66.73 Million | 19.92 Million |
| Earnings before Tax | 165.14 Million | 117.74 Million | 96.02 Million | 101.17 Million | 348.32 Million | 101.76 Million |
| Net Income | 137.01 Million | 93.24 Million | 76.82 Million | 85.38 Million | 281.59 Million | 81.83 Million |
| Earnings Per Share Basic | 1.08 | 0.73 | 0.61 | 0.66 | - | 0.62 |
| Earnings Per Share Diluted | 1.05 | 0.72 | 0.60 | 0.65 | - | 0.61 |
| Weighted Average Shares Outstanding | 126.85 Million | 127.11 Million | 126.94 Million | 129.05 Million | 131.92 Million | 131.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 130.13 Million | 129.22 Million | 128.88 Million | 131.03 Million | 134.19 Million | 134.08 Million |
| Gross Margin | 0.83 | 0.75 | 0.76 | 0.77 | 0.77 | 0.75 |
| EBIT Margin | 0.56 | 0.59 | 0.59 | 0.53 | - | 0.50 |
| Profit Margin | 0.47 | 0.40 | 0.39 | 0.37 | 0.34 | 0.38 |
| EBITDA | 163.19 Million | 137.59 Million | 115.74 Million | 121.72 Million | - | 108.62 Million |
| Earnings Before Tax Margin | 0.56 | 0.51 | 0.49 | 0.44 | 0.41 | 0.41 |
AHEXY
AZTR
603156
ALEFRM
605218
SSCFF